Journal of Reproductive Immunology
Volume 82, Issue 2 , Pages 174-181 , November 2009

Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia

  • Virginie Rigourd

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • Institut de Puériculture de Paris, 26 Boulevard Brune, Paris, France
    • ,
  • Sonia Chelbi

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • ,
  • Caroline Chauvet

      Affiliations

    • Inserm UMR-S747, Université Paris Descartes, Centre Universitaire des Saints Pères 45, Paris, France
    • Université Paris Descartes – Faculté de médecine, Site Necker CNRS UPR 9078 75730 Paris, France
    • ,
  • Régis Rebourcet

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • ,
  • Sandrine Barbaux

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • ,
  • Bettina Bessières

      Affiliations

    • Institut de Puériculture de Paris, 26 Boulevard Brune, Paris, France
    • ,
  • Françoise Mondon

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • ,
  • Thérèse-Marie Mignot

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • ,
  • Jean-Louis Danan

      Affiliations

    • Université Paris Descartes – Faculté de médecine, Site Necker CNRS UPR 9078 75730 Paris, France
    • ,
  • Daniel Vaiman

      Affiliations

    • Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
    • Inserm, U567, Paris, France
    • Corresponding Author InformationCorresponding author at: Equipe 21, Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France.

Received 23 December 2008 ,Revised 31 March 2009 ,Accepted 1 May 2009.

References 

  1. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br. J. Obstet. Gynaecol. 1990;97:762–769
  2. Arngrimsson R, Sigurard ttir S, Frigge ML, Bjarnad ttir RI, Jonsson T, Stefansson H, et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum. Mol. Genet. 1999;8:1799–1805
  3. Anson-Cartwright L, Dawson K, Holmyard D, Fisher SJ, Lazzarini RA, Cross JC. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 2000;25:311–314
  4. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc. Natl. Acad. Sci. U.S.A. 2007;104:3330–3335
  5. Berends AL, Bertoli-Avella AM, de Groot CJ, van Duijn CM, Oostra BA, Steegers EA. STOX1 gene in pre-eclampsia and intrauterine growth restriction. Bjog. 2007;114:1163–1167
  6. Buffat C, Mondon F, Rigourd V, Boubred F, Bessieres B, Fayol L, et al. A hierarchical analysis of transcriptome alterations in intrauterine growth restriction (IUGR) reveals common pathophysiological pathways in mammals. J. Pathol. 2007;213:337–346
  7. Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension. 2007;49:76–83
  8. Chen CP, Chen CY, Yang YC, Su TH, Chen H. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia. Placenta. 2004;25:413–421
  9. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 2005;102:14753–14758
  10. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am. J. Med. Genet. A. 2004;130:365–371
  11. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3
  12. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 2001;344:867–872
  13. Fitzpatrick E, Goring HH, Liu H, Borg A, Forrest S, Cooper DW, et al. Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum. Biol. 2004;76:849–862
  14. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Allen Hogge W, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009;30:15–24
  15. Graves JA. Genomic imprinting, development and disease—is pre-eclampsia caused by a maternally imprinted gene?. Reprod. Fertil. Dev. 1998;10:23–29
  16. Iglesias-Platas I, Monk D, Jebbink J, Buimer M, Boer K, van der Post J, et al. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat. Genet. 2007;39:279–280
  17. Johnson MP, Fitzpatrick E, Dyer TD, Jowett JB, Brennecke SP, Blangero J, et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol. Hum. Reprod. 2007;13:61–67
  18. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol. Hum. Reprod. 2002;8:1129–1135
  19. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, et al. Transient cyclical methylation of promoter DNA. Nature. 2008;452:112–115
  20. Kivinen K, Peterson H, Hiltunen L, Laivuori H, Heino S, Tiala I, et al. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur. J. Hum. Genet. 2007;15:494–497
  21. Laasanen J, Hiltunen M, Romppanen EL, Punnonen K, Mannermaa A, Heinonen S. Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus. Eur. J. Hum. Genet. 2003;11:232–236
  22. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardottir S, et al. A genome-wide scan for preeclampsia in the Netherlands. Eur. J. Hum. Genet. 2001;9:758–764
  23. Moses EK, Fitzpatrick E, Freed KA, Dyer TD, Forrest S, Elliott K, et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol. Hum. Reprod. 2006;12:505–512
  24. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am. J. Hum. Genet. 2000;67:1581–1585
  25. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007;28:487–497
  26. Rigourd V, Chauvet C, Chelbi ST, Rebourcet R, Mondon F, Letourneur F, et al. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS One. 2008;3:e3905
  27. Sibai BM. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?. Hypertension. 2005;46:1252–1253
  28. Sichtig N, Silling S, Steger G. Papillomavirus binding factor (PBF)-mediated inhibition of cell growth is regulated by 14-3-3beta. Arch. Biochem. Biophys. 2007;464:90–99
  29. van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat. Genet. 2005;37:514–519
  30. Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, et al. Gene expression profiling of the human maternal–fetal interface reveals dramatic changes between midgestation and term. Endocrinology. 2007;148:1059–1079
  31. Yang CS, Yu C, Chuang HC, Chang CW, Chang GD, Yao TP, et al. FBW2 targets GCMa to the ubiquitin-proteasome degradation system. J. Biol. Chem. 2005;280:10083–10090
  32. Yu C, Shen K, Lin M, Chen P, Lin C, Chang GD, et al. GCMa regulates the syncytin-mediated trophoblastic fusion. J. Biol. Chem. 2002;277:50062–50068
  33. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008;14:855–862
  34. Zintzaras E, Kitsios G, Harrison GA, Laivuori H, Kivinen K, Kere J, et al. Heterogeneity-based genome search meta-analysis for preeclampsia. Hum. Genet. 2006;120:360–370

PII: S0165-0378(09)00096-5

doi: 10.1016/j.jri.2009.05.001

Journal of Reproductive Immunology
Volume 82, Issue 2 , Pages 174-181 , November 2009

Article Tools

* Image Usage & Resolution